Home » Ligand Launches Bazedoxifene in Japan and Spain
Ligand Launches Bazedoxifene in Japan and Spain
Ligand Pharmaceuticals Incorporated Wednesday announced that its partner Pfizer, Inc. launched Viviant (Bazedoxifene) in Japan for the treatment of postmenopausal osteoporosis.
TheStreet
TheStreet
Upcoming Events
-
07May
-
14May
-
30May